Q1 Revenue Reports at $8.99M
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Apr 30 2026
0mins
Should l Buy TIPT?
Reports Q1 revenue $8.99M vs. $12.97M last year. Reports book value per share $13.42 vs. $12.63 last year.
Trade with 70% Backtested Accuracy
Stop guessing "Should I Buy TIPT?" and start using high-conviction signals backed by rigorous historical data.
Sign up today to access powerful investing tools and make smarter, data-driven decisions.
Analyst Views on TIPT
About TIPT
Tiptree Inc. is a holding company engaged in allocating capital to select small and middle market companies across industries. The Company invests across a variety of industries and asset types, including the insurance, asset management, specialty finance, real estate, and shipping sectors. The Company’s segments include Insurance and Mortgage. The Insurance segment consists of Fortegra Group, LLC (Fortegra), which is a multinational specialty insurance company focused on underwriting complex and niche risks in underserved markets. Fortegra is an underwriting-focused company, with expertise within the admitted and excess and surplus (E&S) insurance lines and capital light fee-based services markets. It owns a diversified group of businesses and investments that are owned and managed separately as Tiptree Capital, which includes its mortgage segment operations. Tiptree Capital consists primarily of its mortgage operations and principal investments.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
Tiptree Reports Q1 2023 Earnings and Strategic Moves
- Earnings Performance: Tiptree reported a GAAP EPS of $0.34 for Q1 2023, indicating financial stability despite potential market volatility that may affect investor confidence.
- Capital Return Initiatives: The company repurchased approximately $5.0 million in shares during the first quarter at an average price of $16.13 per share, which not only enhances EPS but also reflects management's confidence in the company's intrinsic value.
- Dividend Declaration: Tiptree declared a dividend of $0.06 per share to stockholders of record on May 18, 2026, with a payment date of May 26, 2026, providing shareholders with a steady cash flow and enhancing investment appeal.
- Asset Sale Plan: The company agreed to sell Fortegra for $1.65 billion, with an estimated gross proceeds of $1.12 billion pending regulatory approvals, expected to close in mid-2026, which will help optimize asset allocation and enhance financial flexibility.
See More
Fortegra Group's Financial Ratings Under Positive Review
- Positive Rating Outlook: AM Best has maintained a positive review status for Fortegra Group's Financial Strength Rating (FSR) at A- (Excellent) and Long-Term Issuer Credit Ratings (ICR) at 'a-' (Excellent), reflecting its financial stability and market confidence.
- Acquisition Impact Potential: AM Best believes that the acquisition of Fortegra by DB Insurance Co., Ltd., if completed as anticipated, could enhance its financial flexibility, operational scale, and execution capabilities, further elevating its strategic importance in international markets.
- Diverse Business Structure: Fortegra's property/casualty and life/health subsidiaries include various regional companies, such as Life of the South Insurance Company and Bankers Life Insurance Company of Louisiana, showcasing its broad and diversified business portfolio.
- Ongoing Regulatory Assessment: AM Best will continue discussions with Fortegra's management to evaluate the potential impacts of the acquisition on its balance sheet strength, operational performance, and enterprise risk management, ensuring the accuracy and timeliness of the ratings.
See More
Tiptree Reports Q4 Earnings with Tax Concerns
- Earnings Performance: Tiptree reported a GAAP EPS of $0.04 for Q4, which fell short of market expectations, indicating pressure on the company's profitability that could undermine investor confidence.
- Tax Concerns: The market expressed concerns over potential tax leakages related to the sale of Fortegra, which could impose additional financial burdens on the company, thereby impacting future profitability and shareholder returns.
- Market Reaction: Due to worries about tax issues, the market reacted negatively to Tiptree, suggesting that the stock price may be adversely affected, reflecting investor skepticism regarding the company's financial transparency.
- Future Outlook: Despite current challenges, Tiptree must implement measures to improve its financial condition and enhance market trust to achieve sustainable growth and restore profitability in the future.
See More
Tiptree Shareholders Approve Merger Agreement with Fortegra
- Merger Approval: At the Special Meeting, approximately 81% of Tiptree shareholders voted in favor of the merger agreement with Fortegra and DB Insurance, marking a significant milestone in Tiptree's value creation and expected to enhance long-term shareholder value.
- Clear Transaction Structure: The merger will be executed through a wholly owned subsidiary of DB merging with Fortegra, ensuring a smooth transaction process and simplifying subsequent integration efforts.
- Expected Completion Timeline: Tiptree anticipates closing the merger in mid-2026, subject to customary closing conditions including necessary regulatory approvals, which will lay a foundation for future growth.
- Commitment to Transparency: Tiptree will file a Form 8-K with the SEC to report the final voting results from the Special Meeting, demonstrating the company's commitment to shareholder transparency and compliance.
See More
Veradace Urges Tiptree Shareholders to Vote Against Fortegra Sale
- Shareholder Opposition: Veradace Partners L.P., holding 5.1% of Tiptree Inc., urges shareholders to vote against the proposed sale of Fortegra to DB Insurance at the special meeting on December 3, 2025. This proposal is viewed as a rushed deal that overlooked superior alternatives.
- Management Conflicts of Interest: Glass Lewis and Egan-Jones highlight that the deal structure raises questions about management incentives, potentially allowing management to continue siphoning value from shareholders instead of providing immediate payouts. This structure places nearly $1 billion in proceeds without a clear capital return plan, increasing shareholder risk.
- Negative Market Reaction: Following the announcement of the transaction, Tiptree's stock price dropped over 20%, indicating a lack of confidence from the market regarding the deal. Egan-Jones also noted that the deal leaves Tiptree with nearly $1 billion in unallocated cash, giving management discretion to redeploy capital at will.
- Allegations of Analytical Errors: Veradace claims that Institutional Shareholder Services' analysis contains several material errors, failing to fully assess the deal's valuation and potential risks. The conclusions drawn are seen as based on irrelevant factors, neglecting the long-term value implications for shareholders.
See More
Veradace Partners Releases Presentation Urging Tiptree Shareholders to Vote "NO" on the Problematic Proposed Sale of Fortegra to DB Insurance
Veradace's Position on Fortegra Sale: Veradace Partners L.P., a significant shareholder of Tiptree Inc., is urging shareholders to vote against the proposed sale of The Fortegra Group to DB Insurance, citing concerns over undervaluation and a flawed process that does not benefit shareholders.
Call for Restructured Deal: The firm advocates for a restructured deal that would maximize shareholder value and suggests that there are better, tax-efficient alternatives available.
Questions for the Board: Veradace has outlined critical questions for Tiptree's Board of Directors regarding the timing, pricing, and evaluation of the proposed transaction, emphasizing the need for transparency and accountability.
Disclaimer on Investment Advice: The communication from Veradace is not a solicitation for proxy votes and includes disclaimers about the reliability of the information provided, highlighting the speculative nature of forward-looking statements.
See More
Tiptree Reports Q1 2023 Earnings and Strategic Moves
- Earnings Performance: Tiptree reported a GAAP EPS of $0.34 for Q1 2023, indicating financial stability despite potential market volatility that may affect investor confidence.
- Capital Return Initiatives: The company repurchased approximately $5.0 million in shares during the first quarter at an average price of $16.13 per share, which not only enhances EPS but also reflects management's confidence in the company's intrinsic value.
- Dividend Declaration: Tiptree declared a dividend of $0.06 per share to stockholders of record on May 18, 2026, with a payment date of May 26, 2026, providing shareholders with a steady cash flow and enhancing investment appeal.
- Asset Sale Plan: The company agreed to sell Fortegra for $1.65 billion, with an estimated gross proceeds of $1.12 billion pending regulatory approvals, expected to close in mid-2026, which will help optimize asset allocation and enhance financial flexibility.
See More
Fortegra Group's Financial Ratings Under Positive Review
- Positive Rating Outlook: AM Best has maintained a positive review status for Fortegra Group's Financial Strength Rating (FSR) at A- (Excellent) and Long-Term Issuer Credit Ratings (ICR) at 'a-' (Excellent), reflecting its financial stability and market confidence.
- Acquisition Impact Potential: AM Best believes that the acquisition of Fortegra by DB Insurance Co., Ltd., if completed as anticipated, could enhance its financial flexibility, operational scale, and execution capabilities, further elevating its strategic importance in international markets.
- Diverse Business Structure: Fortegra's property/casualty and life/health subsidiaries include various regional companies, such as Life of the South Insurance Company and Bankers Life Insurance Company of Louisiana, showcasing its broad and diversified business portfolio.
- Ongoing Regulatory Assessment: AM Best will continue discussions with Fortegra's management to evaluate the potential impacts of the acquisition on its balance sheet strength, operational performance, and enterprise risk management, ensuring the accuracy and timeliness of the ratings.
See More
Tiptree Reports Q4 Earnings with Tax Concerns
- Earnings Performance: Tiptree reported a GAAP EPS of $0.04 for Q4, which fell short of market expectations, indicating pressure on the company's profitability that could undermine investor confidence.
- Tax Concerns: The market expressed concerns over potential tax leakages related to the sale of Fortegra, which could impose additional financial burdens on the company, thereby impacting future profitability and shareholder returns.
- Market Reaction: Due to worries about tax issues, the market reacted negatively to Tiptree, suggesting that the stock price may be adversely affected, reflecting investor skepticism regarding the company's financial transparency.
- Future Outlook: Despite current challenges, Tiptree must implement measures to improve its financial condition and enhance market trust to achieve sustainable growth and restore profitability in the future.
See More
Tiptree Shareholders Approve Merger Agreement with Fortegra
- Merger Approval: At the Special Meeting, approximately 81% of Tiptree shareholders voted in favor of the merger agreement with Fortegra and DB Insurance, marking a significant milestone in Tiptree's value creation and expected to enhance long-term shareholder value.
- Clear Transaction Structure: The merger will be executed through a wholly owned subsidiary of DB merging with Fortegra, ensuring a smooth transaction process and simplifying subsequent integration efforts.
- Expected Completion Timeline: Tiptree anticipates closing the merger in mid-2026, subject to customary closing conditions including necessary regulatory approvals, which will lay a foundation for future growth.
- Commitment to Transparency: Tiptree will file a Form 8-K with the SEC to report the final voting results from the Special Meeting, demonstrating the company's commitment to shareholder transparency and compliance.
See More
Veradace Urges Tiptree Shareholders to Vote Against Fortegra Sale
- Shareholder Opposition: Veradace Partners L.P., holding 5.1% of Tiptree Inc., urges shareholders to vote against the proposed sale of Fortegra to DB Insurance at the special meeting on December 3, 2025. This proposal is viewed as a rushed deal that overlooked superior alternatives.
- Management Conflicts of Interest: Glass Lewis and Egan-Jones highlight that the deal structure raises questions about management incentives, potentially allowing management to continue siphoning value from shareholders instead of providing immediate payouts. This structure places nearly $1 billion in proceeds without a clear capital return plan, increasing shareholder risk.
- Negative Market Reaction: Following the announcement of the transaction, Tiptree's stock price dropped over 20%, indicating a lack of confidence from the market regarding the deal. Egan-Jones also noted that the deal leaves Tiptree with nearly $1 billion in unallocated cash, giving management discretion to redeploy capital at will.
- Allegations of Analytical Errors: Veradace claims that Institutional Shareholder Services' analysis contains several material errors, failing to fully assess the deal's valuation and potential risks. The conclusions drawn are seen as based on irrelevant factors, neglecting the long-term value implications for shareholders.
See More
Veradace Partners Releases Presentation Urging Tiptree Shareholders to Vote "NO" on the Problematic Proposed Sale of Fortegra to DB Insurance
Veradace's Position on Fortegra Sale: Veradace Partners L.P., a significant shareholder of Tiptree Inc., is urging shareholders to vote against the proposed sale of The Fortegra Group to DB Insurance, citing concerns over undervaluation and a flawed process that does not benefit shareholders.
Call for Restructured Deal: The firm advocates for a restructured deal that would maximize shareholder value and suggests that there are better, tax-efficient alternatives available.
Questions for the Board: Veradace has outlined critical questions for Tiptree's Board of Directors regarding the timing, pricing, and evaluation of the proposed transaction, emphasizing the need for transparency and accountability.
Disclaimer on Investment Advice: The communication from Veradace is not a solicitation for proxy votes and includes disclaimers about the reliability of the information provided, highlighting the speculative nature of forward-looking statements.
See More
